financial guidance Thermo Fisher Scientific Expects 12 Percent Revenue Growth in 2022 The guidance for next year assumes, among other things, $6.0 billion in revenue from clinical research services provider PPD, which Thermo Fisher is set to acquire this year. LumiraDx, CA Healthcare Acquisition Revise Merger Terms to Lower Equity Value of Combined Company The firms said that lowering the pro forma enterprise value of post-merger LumiraDx is expected to make the new company more attractive to investors. SomaLogic Boosts Full-Year 2021 Revenue Guidance by 10 Percent The company said that it expects to exceed its previous full-year 2021 guidance of $66.7 million in revenues by 10 percent or more. Agilent Technologies Q3 Revenues Rise 26 Percent Revenues for Agilent's diagnostic and genomics group rose 44 percent to $346 million from $241 million in the year-ago quarter. 23andMe Q1 Revenues Rise 23 Percent The company said its revenue growth was primarily due to higher sales of its Personal Genome Service kit. May 23, 2012 Thermo Fisher Scientific Eyeing 2016 Revenues of $14.5B to $15.5B Feb 1, 2012 FDA Official Says Personalized Medicine Regulation Taking Shape Following Zelboraf, Xalkori Success Premium Dec 15, 2011 Analysts Lower Complete Genomics' Estimates on Updated Guidance Dec 14, 2011 Danaher Forecasts 2012 Revenue Growth of 2 to 5 Percent Sep 7, 2011 At Dx Conference, FDA's Gutierrez Sheds Further Light on Plans for Risk-Based LDT Regulation Premium Aug 25, 2011 Meridian Sees 20 to 30 Percent Growth in Fiscal 2012 Jul 27, 2011 Illumina's Shares Fall on Cautious Outlook May 19, 2011 Calando Aims to Complete RNAi Phase I Trial, Ink Development Partnership by Year's End Premium Mar 2, 2011 FDA Draft PGx Guidance Urges Early Planning to Anticipate Pre-market Gene-Drug Issues Premium Dec 23, 2010 RXi Selects Candidate in Anti-Scarring Program as Promised, But Will Likely Miss Partnership Goal Premium Dec 1, 2010 FDA's Lesko Provides Update on Personalized Medicine Efforts; Three Guidances Slated for Release Premium Nov 3, 2010 FDA Issues Draft Guidelines on Qualifying Biomarkers to Speed Rx Development Premium Oct 28, 2010 Pfizer Amends In-House RNAi Rx Guidance Premium Aug 31, 2010 PerkinElmer Divests Business; Increases Share Repurchase Program Jul 7, 2010 23andMe Seeks Collaboration with FDA, NIH on Genetic Testing Guidelines Feb 3, 2010 Medco Acquires DNA Direct to Expand PGx Offerings with Genetic Education, Testing Decision Support Premium Jan 14, 2010 Caliper Expects Q4 Revenues to Exceed Guidance Breaking News Exome Sequencing of UK Biobank Participants Highlights Natural Variation, Gene Function Cystic Fibrosis Sinus Infections Involve Microbes With Shifting Evolution Patterns Molecular Assemblies Wins $256K NIH Phase I SBIR Grant to Develop Enzymatic DNA Synthesis Vibrent Health, VCU Partner to Offer Twin Research Platform Castle Biosciences Acquires Cernostics for up to $80M Princess Margaret Cancer Centre, Inivata Partner on Clinical Liquid Biopsy Studies The Scan Could Mix It Up The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says. Closest to the Dog New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs. Offer to Come Back The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back. PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.